Restless legs syndrome and central nervous system gamma-aminobutyric acid: Preliminary associations with periodic limb movements in sleep and restless leg syndrome symptom severity

Sleep Medicine

Volumn 15, Issue 10, 2014, Pages 1225-1230

  Winkelman, John W ^a,b   Schoerning, Laura ^b   Platt, Sam ^b   Jensen, J Eric ^a,c  

^a HARVARD MEDICAL SCHOOL   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c MCLEAN HOSPITAL   (United States)

Author keywords

Anterior cingulate cortex; Cerebellum; Gamma aminobutyric acid; Glutamate; Periodic limb movements of sleep; Restless legs syndrome; Thalamus

Indexed keywords

4 AMINOBUTYRIC ACID; GLUTAMIC ACID; N ACETYLASPARTIC ACID; ASPARTIC ACID; N-ACETYLASPARTATE;

ACTIMETRY; ADULT; ANTERIOR CINGULATE; ARTICLE; CEREBELLUM; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATIONAL STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; HUMAN; MALE; PAIN; PERIODIC LIMB MOVEMENT DISORDER; PROTON NUCLEAR MAGNETIC RESONANCE; RESTLESS LEGS SYNDROME; SENSORY DYSFUNCTION; THALAMUS; ANALOGS AND DERIVATIVES; BRAIN CHEMISTRY; CASE CONTROL STUDY; CHEMISTRY; CINGULATE GYRUS; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; POLYSOMNOGRAPHY; SEVERITY OF ILLNESS INDEX;

ACTIGRAPHY; ADULT; ASPARTIC ACID; BRAIN CHEMISTRY; CASE-CONTROL STUDIES; CEREBELLUM; FEMALE; GAMMA-AMINOBUTYRIC ACID; GLUTAMIC ACID; GYRUS CINGULI; HUMANS; MALE; POLYSOMNOGRAPHY; PROTON MAGNETIC RESONANCE SPECTROSCOPY; RESTLESS LEGS SYNDROME; SEVERITY OF ILLNESS INDEX; THALAMUS;

EID: 84922633233     PISSN: 13899457     EISSN: 18785506     Source Type: Journal    
DOI: 10.1016/j.sleep.2014.05.019     Document Type: Article

References (23)

1. Winkelman J.W., Gagnon A., Clair A.G. Sensory symptoms in restless legs syndrome: the enigma of pain. Sleep Med 2013, 14:934-942.
2. Bucher S.F., Seelos K.C., Dodel R.C., Reiser M., Oertel W.H. Activation mapping in essential tremor with functional magnetic resonance imaging. Ann Neurol 1997, 41:32-40.
3. Margariti P.N., Astrakas L.G., Tsouli S.G., Hadjigeorgiou G.M., Konitsiotis S., Argyropoulou M.I. Investigation of unmedicated early onset restless legs syndrome by voxel-based morphometry, T2 relaxometry, and functional MR imaging during the night-time hours. Am J Neuroradiol 2012, 33:667-672.
4. Cervenka S., Palhagen S.E., Comley R.A., Panagiotidis G., Cselenyi Z., Matthews J.C., et al. Support for dopaminergic hypoactivity in restless legs syndrome: a PET study on D2-receptor binding. Brain 2006, 129(Pt 8):2017-2028.
5. von Spiczak S., Whone A.L., Hammers A., Asselin M.C., Turkheimer F., Tings T., et al. The role of opioids in restless legs syndrome: an [11C]diprenorphine PET study. Brain 2005, 128(Pt 4):906-917.
6. Shackman A.J., Salomons T.V., Slagter H.A., Fox A.S., Winter J.J., Davidson R.J. The integration of negative affect, pain and cognitive control in the cingulate cortex. Nature Rev Neurosci 2011, 12:154-167.
7. Astrakas L.G., Konitsiotis S., Margariti P., Tsouli S., Tzarouhi L., Argyropoulou M.I. T2 relaxometry and fMRI of the brain in late-onset restless legs syndrome. Neurology 2008, 71:911-916.
8. Spiegelhalder K., Feige B., Paul D., Riemann D., van Elst L.T., Seifritz E., et al. Cerebral correlates of muscle tone fluctuations in restless legs syndrome: a pilot study with combined functional magnetic resonance imaging and anterior tibial muscle electromyography. Sleep Med 2008, 9:177-183.
9. Allen R.P., Barker P.B., Horska A., Earley C.J. Thalamic glutamate/glutamine in restless legs syndrome: increased and related to disturbed sleep. Neurology 2013, 80:2028-2034.
10. Rizzo G., Tonon C., Testa C., Manners D., Vetrugno R., Pizza F., et al. Abnormal medial thalamic metabolism in patients with idiopathic restless legs syndrome. Brain 2012, 135(Pt 12):3712-3720.
11. Walters A.S., LeBrocq C., Dhar A., Hening W., Rosen R., Allen R.P., et al. Validation of the International Restless Legs Syndrome Study Group rating scale for restless legs syndrome. Sleep Med 2003, 4:121-132.
12. Buysse D.J., Reynolds C.F., Monk T.H., Berman S.R., Kupfer D.J. The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res 1989, 28:193-213.
13. Beck A.T., Ward C.H., Mendelson M., Mock J., Erbaugh J. An inventory for measuring depression. Archs Gen Psychiatry 1961, 4:561-571.
14. Mescher M., Merkle H., Kirsch J., Garwood M., Gruetter R. Simultaneous in vivo spectral editing and water suppression. NMR Biomed 1998, 11:266-272.
15. Provencher S.W. Estimation of metabolite concentrations from localized in vivo proton NMR spectra. Magnetic Reson Med 1993, 30:672-679.
16. Provencher S.W. Automatic quantitation of localized in vivo 1H spectra with LCModel. NMR Biomed 2001, 14:260-264.
17. Plante D.T., Jensen J.E., Schoerning L., Winkelman J.W. Reduced gamma-aminobutyric acid in occipital and anterior cingulate cortices in primary insomnia: a link to major depressive disorder?. Neuropsychopharmacology 2012, 37:1548-1557.
18. Hoshi E., Tremblay L., Feger J., Carras P.L., Strick P.L. The cerebellum communicates with the basal ganglia. Nature Neurosci 2005, 8:1491-1493.
19. Staedt J., Stoppe G., Kogler A., Munz D., Riemann H., Emrich D., et al. Dopamine D2 receptor alteration in patients with periodic movements in sleep (nocturnal myoclonus). J Neural Transm 1993, 93:71-74.
20. Lerner A., Bagic A., Simmons J.M., Mari Z., Bonne O., Xu B., et al. Widespread abnormality of the gamma-aminobutyric acid-ergic system in Tourette syndrome. Brain 2012, 135(Pt 6):1926-1936.
21. Tsai G., Coyle J.T. N-acetylaspartate in neuropsychiatric disorders. Prog Neurobiol 1995, 46:531-540.
22. Rainville P., Duncan G.H., Price D.D., Carrier B., Bushnell M.C. Pain affect encoded in human anterior cingulate but not somatosensory cortex. Science 1997, 277(5328):968-971.
23. Tracey I., Mantyh P.W. The cerebral signature for pain perception and its modulation. Neuron 2007, 55:377-391.